Cargando…

Staging and imaging of small cell lung cancer

Small cell lung cancer (SCLC) has been primarily classified as limited or extensive, with limited stage confined to the primary tumor and regional lymph nodes. In the future, the TNM staging system should be integrated into the classification of SCLC. The appropriate staging work-up for patients wit...

Descripción completa

Detalles Bibliográficos
Autor principal:	Kalemkerian, Gregory P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	e-Med 2011
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3266593/ https://www.ncbi.nlm.nih.gov/pubmed/22245990 http://dx.doi.org/10.1102/1470-7330.2011.0036

Ejemplares similares

Characterization of pneumonia and other factors leading to poorer survival across all age groups in patients with non-small cell lung cancer (NSCLC)
por: Weinberg, Frank D., et al.
Publicado: (2021)

Immunotherapy in inoperable stage III non-small cell lung cancer: a review
por: Jain, Natasha A, et al.
Publicado: (2019)

Immunotherapy in Extensive-Stage Small Cell Lung Cancer
por: El Sayed, Rola, et al.
Publicado: (2021)

Cellular engagement and interaction in the tumor microenvironment predict non-response to PD-1/PD-L1 inhibitors in metastatic non-small cell lung cancer
por: Qin, Angel, et al.
Publicado: (2022)

PET/CT in the Staging of the Non-Small-Cell Lung Cancer
por: Chao, Fangfang, et al.
Publicado: (2012)

Consolidative thoracic radiotherapy for extensive stage small cell lung cancer
por: Zhang, Xiaoli, et al.
Publicado: (2017)

Advances and Therapeutic Perspectives in Extended-Stage Small-Cell Lung Cancer
por: Pierret, Thomas, et al.
Publicado: (2020)

Prediction of Radiation Esophagitis in Non–Small Cell Lung Cancer Using Clinical Factors, Dosimetric Parameters, and Pretreatment Cytokine Levels()()
por: Hawkins, Peter G., et al.
Publicado: (2017)

Surgery for limited stage small cell lung cancer
por: Gergen, Anna K., et al.
Publicado: (2020)

Immunotherapy for extensive stage small cell lung cancer
por: Pacheco, Jose M.
Publicado: (2020)

Lung Cancer Staging: Imaging and Potential Pitfalls
por: Erasmus, Lauren T., et al.
Publicado: (2023)

Clinical and Surgical-Pathological Staging in Early Non-Small Cell Lung Cancer
por: Koukis, Ioannis, et al.
Publicado: (2013)

Therapeutic management options for stage III non-small cell lung cancer
por: Yoon, Stephanie M, et al.
Publicado: (2017)

Prognosis of segmentectomy in the treatment of stage IA non-small cell lung cancer
por: Bai, Wenliang, et al.
Publicado: (2021)

The Evolving Role of Immunotherapy in Stage III Non-Small Cell Lung Cancer
por: Perdrizet, Kirstin, et al.
Publicado: (2021)

Neoadjuvant and Adjuvant Immunotherapy in Early-Stage Non-Small Cell Lung Cancer
por: Shukla, Nikhil, et al.
Publicado: (2021)

A 2022 Update on Extensive Stage Small-Cell Lung Cancer (SCLC)
por: Oronsky, Bryan, et al.
Publicado: (2022)

Uniportal VATS for Diagnosis and Staging in Non-Small Cell Lung Cancer (NSCLC)
por: Del Campo, Jone Miren, et al.
Publicado: (2023)

Evolving Therapeutic Scenario of Stage III Non-Small-Cell Lung Cancer
por: Baudoux, Nathalie, et al.
Publicado: (2023)

Stage III Non-Small-Cell Lung Cancer: An Overview of Treatment Options
por: Petrella, Francesco, et al.
Publicado: (2023)

Extensive-Stage Small-Cell Lung Cancer: Current Landscape and Future Prospects
por: Saida, Yu, et al.
Publicado: (2023)

Stereotactic radiotherapy for early stage non-small cell lung cancer
por: Ricardi, Umberto, et al.
Publicado: (2015)

Staging non-small cell lung cancer*
por: Quint, Leslie Eisenbud
Publicado: (2007)

Magnetic resonance imaging for N staging in non-small cell lung cancer: A systematic review and meta-analysis
por: Zhang, Yuanyuan, et al.
Publicado: (2015)

Mediastinal staging for non-small cell lung cancer
por: Leiro-Fernández, Virginia, et al.
Publicado: (2021)

High-Throughput Label-Free Isolation of Heterogeneous Circulating Tumor Cells and CTC Clusters from Non-Small-Cell Lung Cancer Patients
por: Zeinali, Mina, et al.
Publicado: (2020)

Role of imaging biomarkers in mutation-driven non-small cell lung cancer
por: Mendoza, Dexter P, et al.
Publicado: (2020)

Gemcitabine: Efficacy in the Treatment of Advanced Stage Nonsquamous Non-Small Cell Lung Cancer
por: Hayashi, Hidetoshi, et al.
Publicado: (2011)

Evidence to Date: Evaluating Pembrolizumab in the Treatment of Extensive-Stage Small-Cell Lung Cancer
por: Riano, Ivy, et al.
Publicado: (2021)

Liquid biopsy for therapy monitoring in early-stage non-small cell lung cancer
por: Nagasaka, Misako, et al.
Publicado: (2021)

Non-small cell lung cancer staging: proposed revisions to the TNM system
por: Schneider, Bryan J.
Publicado: (2008)

Carbon Ion Therapy for Early-Stage Non-Small-Cell Lung Cancer
por: Demizu, Yusuke, et al.
Publicado: (2014)

Targeted therapies for unresectable stage III non-small cell lung cancer
por: Remon, Jordi, et al.
Publicado: (2021)

The current role of surgery and SBRT in early stage of small cell lung cancer
por: Farré, Núria, et al.
Publicado: (2021)

Advances and controversies in the management of early stage non-small cell lung cancer
por: Cilleruelo-Ramos, Angel, et al.
Publicado: (2021)

Combined modality therapy in Stage IIIA non–small cell lung cancer: clarity or confusion despite the highest level of evidence?
por: Jeremic, Branislav, et al.
Publicado: (2017)

Staging of non-small cell lung cancer (NSCLC)
por: Rankin, S C
Publicado: (2006)

Defining the Role of Tyrosine Kinase Inhibitors in Early Stage Non-Small Cell Lung Cancer
por: Lampaki, Sofia, et al.
Publicado: (2015)

Improved outcomes and staging in non-small-cell lung cancer guided by a molecular assay
por: Gupta, Alexander R, et al.
Publicado: (2021)

Immunotherapy in Early-Stage Non-Small Cell Lung Cancer (NSCLC): Current Evidence and Perspectives
por: Lazzari, Chiara, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_lepm72k7jpcn0u2b15thjodipc